Status:
COMPLETED
Single Photon Emission Computed Tomography (SPECT) Lymph Node Mapping
Lead Sponsor:
Washington University School of Medicine
Conditions:
Adenocarcinoma of the Prostate
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine if the planning of radiation treatment of prostate cancer patient can be made more precise by comparing currently planning techniques to an imaging technique ...
Detailed Description
Single photon emission computed tomography (SPECT) uses radioactive tracers and a scanner to record data that a computer constructs into two- or three-dimensional images. A small amount of a radioacti...
Eligibility Criteria
Inclusion
- Patients with biopsy proven adenocarcinoma of the prostate
- Patients with at least one of the following high risk clinical features at the time of presentation:
- Extra-prostatic extension (on palpation or radiographic imaging)
- PSA ≥ 20
- Gleason Score ≥ 8
- Patients scheduled to receive prostatic and pelvic IMRT with ACCULOC® target localization
- Age \> 18 years
- ECOG Performance Status ≤ 2
- Willing and able to sign informed consent document.-
Exclusion
- History of radical prostatectomy
- History of prior pelvic radiation-
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00608920
Start Date
March 1 2007
End Date
April 1 2009
Last Update
May 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110